Abstract
The purposes of this study were to describe mycophenolic acid (MPA) exposure indices and create new tools for MMF dose adjustment in cystic fibrosis (CF) and non-CF lung transplant recipients on MMF and tacrolimus.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
